The mice model market is expected to grow from US$ 1,705.70 million in 2022 to US$ 2,340.90 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2022 to 2028.

The mice model market is driven by growing demand for preclinical research in drug development and biomedical studies. Genetically engineered mice aid in studying human diseases, advancing cancer, immunology, and neurological research. Rising investments in R&D, personalized medicine, and advancements in CRISPR technology further fuel market growth globally.

​Source: The Insight Partners